{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:34:13Z","timestamp":1783488853370,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670720 and 81974124"],"award-info":[{"award-number":["81670720 and 81974124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqn20161071"],"award-info":[{"award-number":["tsqn20161071"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Academic promotion program of Shandong First Medical University","award":["2019RC015"],"award-info":[{"award-number":["2019RC015"]}]},{"name":"Shandong Key R&D Program","award":["2017GSF18129"],"award-info":[{"award-number":["2017GSF18129"]}]},{"name":"Guiding project of the Natural Science Foundation of Fujian","award":["2019D010"],"award-info":[{"award-number":["2019D010"]}]},{"name":"Fujian Young\/Middle-aged Talent Cultivation Project","award":["2019-ZQNB-31"],"award-info":[{"award-number":["2019-ZQNB-31"]}]},{"name":"Xiamen Science and Technology Commission","award":["3502Z20164029"],"award-info":[{"award-number":["3502Z20164029"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dozens of genes are involved in 46, XY differences in sex development (DSD). Notably, about 3\/4 of patients cannot make a clear etiology diagnosis and single gene variant identified cannot fully explain the clinical heterogeneity of 46, XY DSD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>We conducted a systematic clinical analysis of a 46, XY DSD patient, and applied whole-exome sequencing for the genetic analysis of this pedigree. The identified variants were analyzed by bioinformatic analysis and in vitro studies were performed in human embryonic kidney 293T (HEK-293T) cells which were transiently transfected with wild type or variant <jats:italic>NR5A1<\/jats:italic> and <jats:italic>MAP3K1<\/jats:italic> plasmid. Furthermore, protein production of SRY-box transcription factor 9 (SOX9) was analyzed in cell lysates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A novel <jats:italic>NR5A1<\/jats:italic> variant (c.929A\u2009&gt;\u2009C, p. His310Pro) and a rare <jats:italic>MAP3K1<\/jats:italic> variant (c.2282T\u2009&gt;\u2009C, p. Ile761Thr) were identified in the proband, whereas the proband's mother and sister who only carry rare <jats:italic>MAP3K1<\/jats:italic> variant have remained phenotypically healthy to the present. These two variants were predicted to be pathogenic by bioinformatic analysis. In vitro, <jats:italic>NR5A1<\/jats:italic> variant decreased the SOX9 production by 82.11% compared to wild type <jats:italic>NR5A1<\/jats:italic>, while <jats:italic>MAP3K1<\/jats:italic> variant had little effect on the SOX9 production compared to wild type <jats:italic>MAP3K1<\/jats:italic>. Compared to wild type <jats:italic>NR5A1<\/jats:italic> transfection, the SOX9 production of cells transfected with both wild type plasmids decreased by about 17.40%. Compared to variant <jats:italic>NR5A1<\/jats:italic> transfection, the SOX9 production of cells transfected with both variant plasmids increased by the 36.64%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings suggested the novel compound variants of <jats:italic>NR5A1<\/jats:italic> and <jats:italic>MAP3K1<\/jats:italic> can alter the expression of SOX9 and ultimately lead to abnormality of sex development.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-01908-z","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T22:04:08Z","timestamp":1623362648000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Characteristics and possible mechanisms of 46, XY differences in sex development caused by novel compound variants in NR5A1 and MAP3K1"],"prefix":"10.1186","volume":"16","author":[{"given":"Yiping","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangfei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6743-8881","authenticated-orcid":false,"given":"Chao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"1908_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ogc.2009.02.001","volume":"36","author":"L Allen","year":"2009","unstructured":"Allen L. Disorders of sexual development. Obstet Gynecol Clin N Am. 2009;36:25\u201345.","journal-title":"Obstet Gynecol Clin N Am"},{"key":"1908_CR2","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1210\/jc.2016-2248","volume":"101","author":"A Berglund","year":"2016","unstructured":"Berglund A, Johannsen TH, Stochholm K, Viuff MH, Fedder J, Main KM, Gravholt CH. Incidence, prevalence, diagnostic delay, and clinical presentation of female 46, XY disorders of sex development. J Clin Endocrinol Metab. 2016;101:4532\u201340.","journal-title":"J Clin Endocrinol Metab"},{"key":"1908_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ajhb.10122","volume":"15","author":"CL Hull","year":"2003","unstructured":"Hull CL, Fausto-Sterling A. How sexually dimorphic are we? Review and synthesis. Am J Hum Biol. 2003;15:112\u20135 (author reply 115-6).","journal-title":"Am J Hum Biol."},{"key":"1908_CR4","first-page":"413","volume":"19","author":"K Wertheim-Tysarowska","year":"2015","unstructured":"Wertheim-Tysarowska K, Gos M, Sykut-Cegielska J, Bal J. Genetic analysis in inherited metabolic disorders\u2014from diagnosis to treatment. Own experience, current state of knowledge and perspectives. Dev Period Med. 2015;19:413\u201331.","journal-title":"Dev Period Med"},{"key":"1908_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11934-015-0556-0","volume":"16","author":"AY Rawal","year":"2015","unstructured":"Rawal AY, Austin PF. Concepts and updates in the evaluation and diagnosis of common disorders of sexual development. Curr Urol Rep. 2015;16:83.","journal-title":"Curr Urol Rep"},{"key":"1908_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13059-016-1105-y","volume":"17","author":"S Eggers","year":"2016","unstructured":"Eggers S, Sadedin S, van den Bergen JA, Robevska G, Ohnesorg T, Hewitt J, Lambeth L, et al. Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort. Genome Biol. 2016;17:243.","journal-title":"Genome Biol"},{"key":"1908_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.mce.2010.11.006","volume":"336","author":"B Ferraz-de-Souza","year":"2011","unstructured":"Ferraz-de-Souza B, Lin L, Achermann JC. Steroidogenic factor-1 (SF-1, NR5A1) and human disease. Mol Cell Endocrinol. 2011;336:198\u2013205.","journal-title":"Mol Cell Endocrinol"},{"key":"1908_CR8","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1128\/MCB.18.11.6653","volume":"18","author":"BP De Santa","year":"1998","unstructured":"De Santa BP, Bonneaud N, Boizet B, Desclozeaux M, Moniot B, Sudbeck P, Scherer G, et al. Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene. Mol Cell Biol. 1998;18:6653\u201365.","journal-title":"Mol Cell Biol"},{"key":"1908_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nature06944","volume":"453","author":"R Sekido","year":"2008","unstructured":"Sekido R, Lovell-Badge R. Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature. 2008;453:930\u20134.","journal-title":"Nature"},{"key":"1908_CR10","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1210\/me.2009-0519","volume":"24","author":"BP Schimmer","year":"2010","unstructured":"Schimmer BP, White PC. Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease. Mol Endocrinol. 2010;24:1322\u201337.","journal-title":"Mol Endocrinol"},{"key":"1908_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000342221","volume":"7","author":"R Sekido","year":"2013","unstructured":"Sekido R, Lovell-Badge R. Genetic control of testis development. Sex Dev. 2013;7:21\u201332.","journal-title":"Sex Dev"},{"key":"1908_CR12","doi-asserted-by":"publisher","first-page":"E1294","DOI":"10.1210\/jc.2011-3169","volume":"97","author":"N Camats","year":"2012","unstructured":"Camats N, Pandey AV, Fern\u00e1ndez-Cancio M, Andaluz P, Janner M, Tor\u00e1n N, Moreno F, et al. Ten novel mutations in the NR5A1 gene cause disordered sex development in 46, XY and ovarian insufficiency in 46, XX individuals. J Clin Endocrinol Metab. 2012;97:E1294\u2013306.","journal-title":"J Clin Endocrinol Metab"},{"key":"1908_CR13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/MED.0000000000000113","volume":"21","author":"TF King","year":"2014","unstructured":"King TF, Conway GS. Swyer syndrome. Curr Opin Endocrinol Diabetes Obes. 2014;21:504\u201310.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1908_CR14","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1507\/endocrj.EJ18-0218","volume":"65","author":"M Adachi","year":"2018","unstructured":"Adachi M, Hasegawa T, Tanaka Y, Asakura Y, Hanakawa J, Muroya K. Spontaneous virilization around puberty in NR5A1-related 46, XY sex reversal: additional case and a literature review. Endocr J. 2018;65:1187\u201392.","journal-title":"Endocr J"},{"key":"1908_CR15","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/s41431-018-0202-7","volume":"26","author":"N Camats","year":"2018","unstructured":"Camats N, Fernandez-Cancio M, Audi L, Schaller A, Fluck CE. Broad phenotypes in heterozygous NR5A1 46, XY patients with a disorder of sex development: an oligogenic origin? Eur J Hum Genet. 2018;26:1329\u201338.","journal-title":"Eur J Hum Genet"},{"key":"1908_CR16","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.ajhg.2010.11.003","volume":"87","author":"A Pearlman","year":"2010","unstructured":"Pearlman A, Loke J, Le Caignec C, White S, Chin L, Friedman A, Warr N, et al. Mutations in MAP3K1 cause 46, XY disorders of sex development and implicate a common signal transduction pathway in human testis determination. Am J Hum Genet. 2010;87:898\u2013904.","journal-title":"Am J Hum Genet"},{"key":"1908_CR17","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1210\/jc.2013-3690","volume":"99","author":"H Ostrer","year":"2014","unstructured":"Ostrer H. Disorders of sex development (DSDs): an update. J Clin Endocrinol Metab. 2014;99:1503\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1908_CR18","doi-asserted-by":"publisher","first-page":"e90771","DOI":"10.1371\/journal.pone.0090771","volume":"9","author":"Q Zheng","year":"2014","unstructured":"Zheng Q, Ye J, Wu H, Yu Q, Cao J. Association between mitogen-activated protein kinase kinase kinase 1 polymorphisms and breast cancer susceptibility: a meta-analysis 20 of case-control studies. PLoS ONE. 2014;9:e90771.","journal-title":"PLoS ONE"},{"key":"1908_CR19","doi-asserted-by":"publisher","first-page":"BSR20200616","DOI":"10.1042\/BSR20200616","volume":"40","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Sun Y, Ji Y, Jiang D, Teng G, Zhou X, Zhou X, et al. Novel compound variants of the AR and MAP3K1 genes are related to the clinical heterogeneity of androgen insensitivity syndrome. Biosci Rep. 2020;40:BSR20200616.","journal-title":"Biosci Rep"},{"key":"1908_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mce.2009.07.003","volume":"315","author":"EA Hoivik","year":"2010","unstructured":"Hoivik EA, Lewis AE, Aumo L, Bakke M. Molecular aspects of steroidogenic factor 1 (SF-1). Mol Cell Endocrinol. 2010;315:27\u201339.","journal-title":"Mol Cell Endocrinol"},{"key":"1908_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1210\/edrv.18.3.0301","volume":"18","author":"KL Parker","year":"1997","unstructured":"Parker KL, Schimmer BP. Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr Rev. 1997;18:361\u201377.","journal-title":"Endocr Rev"},{"key":"1908_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1677\/jme.0.0170139","volume":"17","author":"M Wong","year":"1996","unstructured":"Wong M, Ramayya MS, Chrousos GP, Driggers PH, Parker KL. Cloning and sequence analysis of the human gene encoding steroidogenic factor 1. J Mol Endocrinol. 1996;17:139\u201347.","journal-title":"J Mol Endocrinol"},{"key":"1908_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/cge.12912","volume":"91","author":"D Alhomaidah","year":"2017","unstructured":"Alhomaidah D, McGowan R, Ahmed SF. The current state of diagnostic genetics for conditions affecting sex development. Clin Genet. 2017;91:157\u201362.","journal-title":"Clin Genet"},{"key":"1908_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000445983","volume":"10","author":"I Mazen","year":"2016","unstructured":"Mazen I, Abdel-Hamid M, Mekkawy M, Bignon-Topalovic J, Boudjenah R, El Gammal M, Essawi M, et al. Identification of NR5A1 mutations and possible digenic inheritance in 46. XY Gonadal Dysgenesis Sex Dev. 2016;10:147\u201351.","journal-title":"XY Gonadal Dysgenesis Sex Dev"},{"key":"1908_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/gim.2016.118","volume":"19","author":"D Baetens","year":"2017","unstructured":"Baetens D, Stoop H, Peelman F, Todeschini AL, Rosseel T, Coppieters F, Veitia RA, et al. NR5A1 is a novel disease gene for 46, XX testicular and ovotesticular disorders of sex development. Genet Med. 2017;19:367\u201376.","journal-title":"Genet Med"},{"key":"1908_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00439-018-1879-y","volume":"137","author":"H Wang","year":"2018","unstructured":"Wang H, Zhang L, Wang N, Zhu H, Han B, Sun F, Yao H, et al. Next-generation sequencing reveals genetic landscape in 46, XY disorders of sexual development patients with variable phenotypes. Hum Genet. 2018;137:265\u201377.","journal-title":"Hum Genet"},{"key":"1908_CR27","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1093\/hmg\/ddz002","volume":"28","author":"A Chamberlin","year":"2019","unstructured":"Chamberlin A, Huether R, Machado AZ, Groden M, Liu HM, Upadhyay KOV, et al. Mutations in MAP3K1 that cause 46, XY disorders of sex development disrupt distinct structural domains in the protein. Hum Mol Genet. 2019;28:1620\u20138.","journal-title":"Hum Mol Genet"},{"key":"1908_CR28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1073\/pnas.97.3.1113","volume":"97","author":"S Murakami","year":"2000","unstructured":"Murakami S, Kan M, McKeehan WL, de Crombrugghe B. Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA. 2000;97:1113\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1908_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/cge.13165","volume":"93","author":"K Upadhyay","year":"2018","unstructured":"Upadhyay K, Loke JOV, Taragin B, Ostrer H. Biallelic mutations in FLNB cause a skeletal dysplasia with 46, XY gonadal dysgenesis by activating beta-catenin. Clin Genet. 2018;93:412\u20136.","journal-title":"Clin Genet."},{"key":"1908_CR30","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1128\/MCB.19.7.5143","volume":"19","author":"MT Abreu-Martin","year":"1999","unstructured":"Abreu-Martin MT, Chari A, Palladino AA, Craft NA, Sawyers CL. Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer. Mol Cell Biol. 1999;19:5143\u201354.","journal-title":"Mol Cell Biol"},{"key":"1908_CR31","doi-asserted-by":"publisher","first-page":"6379","DOI":"10.1074\/jbc.271.11.6379","volume":"271","author":"KB Cleutjens","year":"1996","unstructured":"Cleutjens KB, van Eekelen CC, van der Korput HA, Brinkmann AO, Trapman J. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J Biol Chem. 1996;271:6379\u201388.","journal-title":"J Biol Chem"},{"key":"1908_CR32","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.2337\/db07-1670","volume":"57","author":"D Mokhtari","year":"2008","unstructured":"Mokhtari D, Myers JW, Welsh N. MAPK kinase kinase-1 is essential for cytokine-induced c-Jun NH2-terminal kinase and nuclear factor-kappaB activation in human pancreatic islet cells. Diabetes. 2008;57:1896\u2013904.","journal-title":"Diabetes"},{"key":"1908_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.mce.2016.09.010","volume":"439","author":"DA Leach","year":"2017","unstructured":"Leach DA, Panagopoulos V, Nash C, Bevan C, Thomson AA, Selth LA, Buchanan G. Cell-lineage specificity and role of AP-1 in the prostate fibroblast androgen receptor cistrome. Mol Cell Endocrinol. 2017;439:261\u201372.","journal-title":"Mol Cell Endocrinol"},{"key":"1908_CR34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/humu.23354","volume":"39","author":"G Robevska","year":"2018","unstructured":"Robevska G, van den Bergen JA, Ohnesorg T, Eggers S, Hanna C, Hersmus R, Thompson EM, et al. Functional characterization of novel NR5A1 variants reveals multiple complex roles in disorders of sex development. Hum Mutat. 2018;39:124\u201339.","journal-title":"Hum Mutat"},{"key":"1908_CR35","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1128\/MCB.19.6.4495","volume":"19","author":"JR Lu","year":"1999","unstructured":"Lu JR, McKinsey TA, Xu H, Wang DZ, Richardson JA, Olson EN. FOG-2, a heart- and brain-enriched cofactor for GATA transcription factors. Mol Cell Biol. 1999;19:4495\u2013502.","journal-title":"Mol Cell Biol"},{"key":"1908_CR36","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0092-8674(00)80885-5","volume":"101","author":"SG Tevosian","year":"2000","unstructured":"Tevosian SG, Deconinck AE, Tanaka M, Schinke M, Litovsky SH, Izumo S, Fujiwara Y, et al. FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium. Cell. 2000;101:729\u201339.","journal-title":"Cell"},{"key":"1908_CR37","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1093\/hmg\/ddu074","volume":"23","author":"A Bashamboo","year":"2014","unstructured":"Bashamboo A, Brauner R, Bignon-Topalovic J, Lortat-Jacob S, Karageorgou V, Lourenco D, Guffanti A, et al. Mutations in the FOG2\/ZFPM2 gene are associated with anomalies of human testis determination. Hum Mol Genet. 2014;23:3657\u201365.","journal-title":"Hum Mol Genet"},{"key":"1908_CR38","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.devcel.2013.06.018","volume":"26","author":"Y Fujimoto","year":"2013","unstructured":"Fujimoto Y, Tanaka SS, Yamaguchi YL, Kobayashi H, Kuroki S, Tachibana M, Shinomura M, et al. Homeoproteins Six1 and Six4 regulate male sex determination and mouse gonadal development. Dev Cell. 2013;26:416\u201330.","journal-title":"Dev Cell"},{"key":"1908_CR39","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/1521-1878(200007)22:7<616::AID-BIES4>3.0.CO;2-R","volume":"22","author":"K Kawakami","year":"2000","unstructured":"Kawakami K, Sato S, Ozaki H, Ikeda K. Six family genes\u2013structure and function as transcription factors and their roles in development. BioEssays. 2000;22:616\u201326.","journal-title":"BioEssays"},{"key":"1908_CR40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/(SICI)1097-0177(200003)217:3<293::AID-DVDY7>3.0.CO;2-P","volume":"217","author":"BP de Santa","year":"2000","unstructured":"de Santa BP, Moniot B, Poulat F, Berta P. Expression and subcellular localization of SF-1, SOX9, WT1, and AMH proteins during early human testicular development. Dev Dyn. 2000;217:293\u20138.","journal-title":"Dev Dyn"},{"key":"1908_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s42000-018-0013-9","volume":"17","author":"A Avendano","year":"2018","unstructured":"Avendano A, Paradisi I, Cammarata-Scalisi F, Callea M. 5-alpha-Reductase type 2 deficiency: is there a genotype-phenotype correlation? A review. Hormones (Athens). 2018;17:197\u2013204.","journal-title":"Hormones (Athens)"},{"key":"1908_CR42","first-page":"577","volume":"14","author":"JD Wilson","year":"1993","unstructured":"Wilson JD, Griffin JE, Russell DW. Steroid 5 alpha-reductase 2 deficiency. Endocr Rev. 1993;14:577\u201393.","journal-title":"Endocr Rev"},{"key":"1908_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ajmg.c.31559","volume":"175","author":"A Granados","year":"2017","unstructured":"Granados A, Alaniz VI, Mohnach L, Barseghyan H, Vilain E, Ostrer H, Quint EH, et al. MAP3K1-related gonadal dysgenesis: Six new cases and review of the literature. Am J Med Genet C Semin Med Genet. 2017;175:253\u20139.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"1908_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ajmg.a.10820","volume":"116a","author":"C Le Caignec","year":"2003","unstructured":"Le Caignec C, Baron S, McElreavey K, Joubert M, Rival JM, Mechinaud F, David A. 46, XY gonadal dysgenesis: evidence for autosomal dominant transmission in a large kindred. Am J Med Genet A. 2003;116a:37\u201343.","journal-title":"Am J Med Genet A."},{"key":"1908_CR45","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s12020-018-1670-9","volume":"62","author":"RA Condorelli","year":"2018","unstructured":"Condorelli RA, Cannarella R, Calogero AE, La Vignera S. Evaluation of testicular function in prepubertal children. Endocrine. 2018;62:274\u201380.","journal-title":"Endocrine"},{"key":"1908_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2350\/12-04-1184-PB.1","volume":"18","author":"M Nistal","year":"2015","unstructured":"Nistal M, Paniagua R, Gonz\u00e1lez-Peramato P, Reyes-M\u00fagica M. Perspectives in pediatric pathology, chapter 1. Normal development of testicular structures: from the bipotential gonad to the fetal testis. Pediatr Dev Pathol. 2015;18:88\u2013102.","journal-title":"Pediatr Dev Pathol."},{"key":"1908_CR47","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/jcm9030780","volume":"9","author":"S La Vignera","year":"2020","unstructured":"La Vignera S, Cannarella R, Condorelli RA, Calogero AE. Disorders of puberty: endocrinology of the pre-pubertal testis. J Clin Med. 2020;9:780.","journal-title":"J Clin Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01908-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01908-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01908-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T22:04:39Z","timestamp":1623362679000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01908-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1908"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01908-z","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"assertion":[{"value":"12 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the manuscript and agreed with the submission and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no multiplicity of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"268"}}